$Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome$

Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome

Aims To investigate the therapeutic effect of recombinant tissue plasminogen activator (r-tPA) in patients with refractory toxic anterior chamber segment syndrome after cataract surgery with posterior chamber intraocular lens implantation. Methods This prospective cohort study was performed from May...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of ophthalmology 2014-02, Vol.98 (2), p.252-255
Hauptverfasser:	Dotan, Assaf, Kaiserman, Igor, Kremer, Israel, Ehrlich, Rita, Bahar, Irit
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anterior Chamber Anterior Eye Segment Cataract Extraction - adverse effects Endophthalmitis - drug therapy Endophthalmitis - etiology Female Fibrinolytic Agents - administration & dosage Follow-Up Studies Humans Injections Male Prospective Studies Recombinant Proteins - administration & dosage Syndrome Tissue Plasminogen Activator - administration & dosage Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!